| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 11,669 | 12,528 | 10,904 | 17,872 | | Cost of Revenue | 8,675 | 8,946 | 8,547 | 11,786 | | | Gross Profit | 2,994 | 3,582 | 2,357 | 6,086 | | | Operating Expenses | | Research Development | (18) | 151 | 152 | 224 | | Selling General and Administrative | 3,448 | 3,733 | 3,102 | 4,483 | | Non Recurring |
-
|
-
| 1,682 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (436) | (302) | (2,579) | 1,379 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (33) | (14) | 61 | | Earnings Before Interest And Taxes | (521) | (335) | (2,593) | 1,440 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (521) | (335) | (2,593) | 1,440 | | Income Tax Expense | (320) | (100) | (580) | 580 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (201) | (235) | (2,013) | 860 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (201) | (235) | (2,013) | 860 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($201) | ($235) | ($2,013) | $860 |
|
0.51% Nasdaq 
Income Statement
